Email this Article

Past Issues | Current Issue

Complete this form to e-mail a link to this article to a friend or colleague.

Comment on: Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real-life ELU study

Dan Calugaru and Mihai Calugaru.Comment on: Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real-life ELU study.Int J Ophthalmol 2021;14(7):1127-1128
E-mail to: (to whom you're sending this)
Your e-mail address:
Your name:
Your comments to add to the e-mail:
Verification code: